The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...

Arcellx (NASDAQ:ACLX) announced an update for its Phase 3 iMMagine-3 study and plans to present Phase 1 and 2 data for its therapy candidate anito-cel for the treatment of multiple myeloma. The ...

Medications like Ozempic and Wegovy, which are used to treat type 2 diabetes and boost weight loss, may also help reduce knee ...

Biopharmaceutical company Angitia Biopharmaceuticals has begun a Phase II clinical trial of AGA2118, a bispecific antibody designed for treating osteoporosis. The first patient has been dosed in the ...

Anavex announced new data from their phase 2b/3 Alzheimer's trial, which was presented at the CTAD 2024 conference. Read why ...

The study is evaluating AJ1-11095, a novel agent for the treatment of myelofibrosis that did not respond to or relapsed ...

Compass Pathways' latest update reveals extended trial timelines, staff cuts, and financial concerns, raising questions about ...

Three phase 3 trials of combinations including datopotamab deruxtecan for the treatment of non–small cell lung cancer are beginning.

The phase 2 INVINCIBLE-4 clinical trial is currently underway in patients with localized triple-negative breast cancer.

The path from a scientist’s initial idea to a new medicine that can save lives is a complex and often lengthy process. It ...

A first healthy adults group has been dosed in an early clinical trial of an oral and myelin-protective treatment for all types of MS.

Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% ...